S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

EVOK Evoke Pharma Inc

4.42

0.00 (0.00%)

Pre Market

Last Updated: 23:00:00

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

Evoke Pharma (NASDAQ:EVOK)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Evoke Pharma Charts.

Evoke Pharma (NASDAQ:EVOK)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Evoke Pharma Charts.

Evoke Pharma Inc News

Evoke Pharma Highlights GIMOTI as a Leading Solution for Gastroparesis Treatment as Domperidone Supply Ends
Friday 20 December 2024 (2 weeks ago) • GlobeNewswire Inc.

Evoke Pharma Receives Notices of Allowance for Two Additional US Patent Applications Protecting GIMOTI®
Wednesday 4 December 2024 (4 weeks ago) • GlobeNewswire Inc.

Form 424B5 - Prospectus [Rule 424(b)(5)]
Saturday 23 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Saturday 16 November 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 15 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 8 November 2024 (2 months ago) • Edgar (US Regulatory)

Evoke Pharma, Inc. Reports Third Quarter 2024 Financial Results
Friday 8 November 2024 (2 months ago) • GlobeNewswire Inc.

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Thursday 7 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 28 October 2024 (2 months ago) • Edgar (US Regulatory)

Evoke Pharma & EVERSANA Announce Statistically Significant Improvement in Patient Outcomes for GLP-1 users with Diabetic Gastroparesis using GIMOTI®
Monday 28 October 2024 (2 months ago) • GlobeNewswire Inc.

Evoke Pharma to Showcase Award-Winning Research at the 2024 American College of Gastroenterology Annual Scientific Meeting
Wednesday 23 October 2024 (2 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 23 October 2024 (2 months ago) • Edgar (US Regulatory)

More Evoke Pharma Inc News Articles

Newcrest Mining

Woodside Petroleum

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions